You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 22, 11 DECEMBER 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fecal Occult Blood Screening for Colorectal Cancer

Jacques Van Dam, MD, PhD; John H. Bond, MD; Michael V. Sivak, Jr, MD

Arch Intern Med. 1995;155(22):2389-2402.


Abstract

We critically analyzed the current literature on fecal occult blood testing as it pertains to colorectal cancer screening. We used articles published or referenced in the major English-language medical and gastroenterology journals for the last 10 years. Large, randomized controlled trials, case-control and cohort studies, and other sources containing information pertinent to the application of fecal occult blood testing for colorectal cancer screening were selected. Although the fecal occult blood test results are capable of predicting the presence of colorectal cancers and polyps, the sensitivity is variable in different studies and low for the latter. Nevertheless, most reports of its use emphasize that a relatively high percentage of the cancers detected are early-stage lesions. Currently available methods for colorectal cancer screening are imperfect, thereby increasing the cost-effectiveness ratio. The fecal occult blood test remains a workable approach to reducing the mortality from colorectal cancer provided it is carried out with attention to important variables such as the need for compliance, including the compliance of physicians.

(Arch Intern Med. 1995;155:2389-2402)



Author Affiliations

From the Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Dr Van Dam); Minneapolis Department of Veterans Affairs Medical Center, University of Minnesota (Dr Bond); and University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Sivak).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
Tibble et al.
Gut 2001;49:402-408.
ABSTRACT | FULL TEXT  

Occult Gastrointestinal Bleeding
Rockey
NEJM 1999;341:38-46.
FULL TEXT  

CLINICAL GUIDELINE: PART II: Screening for Colorectal Cancer with the Fecal Occult Blood Test: A Background Paper
Ransohoff and Lang
ANN INTERN MED 1997;126:811-822.
ABSTRACT | FULL TEXT  

Screening for Colorectal Cancer: A Comparison of 3 Fecal Occult Blood Tests
Levin et al.
Arch Intern Med 1997;157:970-976.
ABSTRACT  

Improving the Fecal Occult-Blood Test
Allison et al.
NEJM 1996;334:1607-1608.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.